John F Smyth Selected Research

John F Smyth Research Topics

Disease

20	Ovarian Neoplasms (Ovarian Cancer) 01/2012 - 04/2002
15	Neoplasms (Cancer) 01/2012 - 04/2002
5	Ovarian Epithelial Carcinoma 09/2008 - 04/2002
4	Neoplasm Metastasis (Metastasis) 04/2012 - 12/2005
3	Carcinoma (Carcinomatosis) 08/2005 - 12/2002
3	Colorectal Neoplasms (Colorectal Cancer) 02/2004 - 02/2002
3	Colonic Neoplasms (Colon Cancer) 01/2004 - 02/2002
1	Melanoma (Melanoma, Malignant) 04/2012
1	Inflammation (Inflammations) 01/2012
1	Brain Neoplasms (Brain Tumor) 12/2010
1	Ascites 10/2009
1	Myalgia 05/2008
1	Lymphoma (Lymphomas) 05/2008
1	Disease Progression 06/2007
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Adenocarcinoma 11/2002

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2009 - 04/2002
5	Letrozole (Femara)FDA LinkGeneric 09/2008 - 07/2002
5	Estrogen ReceptorsIBA 09/2007 - 07/2002
5	Messenger RNA (mRNA)IBA 09/2007 - 12/2002
4	Aromatase InhibitorsIBA 09/2007 - 07/2002
4	Topoisomerase I InhibitorsIBA 01/2004 - 02/2002
3	ParaffinIBA 09/2007 - 07/2002
3	Estrogens (Estrogen)FDA Link 09/2007 - 12/2005
3	ErbB Receptors (EGF Receptor)IBA 08/2005 - 07/2002
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2004 - 02/2002
3	Pharmaceutical PreparationsIBA 01/2004 - 07/2003
2	CytokinesIBA 01/2012 - 10/2009
2	Small Interfering RNA (siRNA)IBA 01/2012 - 06/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2010 - 07/2002
2	Biomarkers (Surrogate Marker)IBA 09/2008 - 07/2002
2	Indicators and Reagents (Reagents)IBA 09/2007 - 03/2007
2	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2007 - 03/2005
2	Protein Isoforms (Isoforms)IBA 04/2006 - 12/2002
2	PlatinumIBA 08/2005 - 11/2002
2	Cisplatin (Platino)FDA LinkGeneric 08/2005 - 11/2002
2	NU-ICRF 505IBA 01/2004 - 02/2002
2	Uridine Diphosphate (UDP)IBA 01/2004 - 12/2003
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2003 - 02/2002
1	Galectin 3 (LGALS3)IBA 04/2012
1	ChemokinesIBA 01/2012
1	Neutralizing AntibodiesIBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	AntibodiesIBA 01/2012
1	Biological ProductsIBA 12/2010
1	AntigensIBA 12/2010
1	Interleukin-23 (Interleukin 23)IBA 10/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2009
1	Interleukin-17 (Interleukin 17)IBA 10/2009
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2009
1	Infliximab (Remicade)FDA Link 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009
1	Integrin alpha3IBA 06/2009
1	matrigelIBA 06/2009
1	WW Domain-Containing OxidoreductaseIBA 06/2009
1	Fibronectins (Fibronectin)IBA 06/2009
1	Hormones (Hormone)IBA 09/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 05/2008
1	plitidepsin (aplidine)IBA 05/2008
1	EnzymesIBA 05/2008
1	Aromatase (CYP19)IBA 09/2007
1	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2007
1	Insulin-Like Growth Factor Binding ProteinsIBA 03/2007
1	Insulin-Like PeptidesIBA 03/2007
1	pertuzumabIBA 01/2007
1	heregulin beta1IBA 01/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2006
1	Complementary DNA (cDNA)IBA 12/2005
1	Estrogen Receptor betaIBA 12/2005
1	Estrogen Receptor alphaIBA 12/2005
1	Cell Adhesion MoleculesIBA 08/2005
1	Phospholipase C gammaIBA 03/2005
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 03/2005
1	ISIS 5132IBA 03/2004
1	Antisense OligonucleotidesIBA 03/2004
1	DNA (Deoxyribonucleic Acid)IBA 02/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2004
1	GlucuronidesIBA 01/2004
1	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2004
1	Carrier Proteins (Binding Protein)IBA 01/2004
1	multidrug resistance-associated protein 1IBA 01/2004
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	IsoenzymesIBA 12/2003
1	Food Additives (Food Additive)IBA 12/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2003
1	NeuregulinsIBA 12/2002
1	matriptaseIBA 04/2002
1	HGF activatorIBA 04/2002
1	Serine Proteases (Serine Protease)IBA 04/2002
1	AnthraquinonesIBA 02/2002
1	trioctyl phosphine oxide (TOPO)IBA 02/2002
1	Tyrosine (L-Tyrosine)FDA Link 02/2002

Therapy/Procedure

7	Therapeutics 09/2008 - 11/2002
5	Drug Therapy (Chemotherapy) 08/2005 - 11/2002
1	Intravenous Infusions 05/2008